HyperMed Overview
- Year Founded
-
1997
- Status
-
Acquired/Merged
- Employees
-
7
- Latest Deal Type
-
M&A
HyperMed General Information
Description
Developer of medical imaging devices designed to deliver diagnostic information in a smaller, portable configuration. The company's devices use a proprietary spectrometer to measure light absorption in blood molecules to determine levels of oxyhemoglobin and deoxyhemoglobin and oxygen saturation in superficial tissue and provide data and a color-coded map of tissue oximetry values, enabling clinical practitioners to improve the lives of patients suffering from complications of vascular disease and diabetes.
Contact Information
Website
www.hypermed.com(Operating Subsidiary)
Corporate Office
- 8700 Trail Lake Drive West
- Suite 200
- Memphis, TN 38125
- United States
Corporate Office
- 8700 Trail Lake Drive West
- Suite 200
- Memphis, TN 38125
- United States
HyperMed Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 11-May-2025 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series C) | 04-Apr-2018 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 01-Dec-2014 | Completed | Generating Revenue | |||
| 4. Restart - Later VC | 23-Dec-2011 | Completed | Restart | |||
| 3. Bankruptcy: Admin/Reorg | 23-Dec-2009 | Completed | Bankruptcy: Admin/Reorg | |||
| 2. Later Stage VC (Series B) | 23-May-2008 | $4M | $9M | Completed | Generating Revenue | |
| 1. Later Stage VC (Series A) | 28-Feb-2007 | $5M | $5M | Completed | Generating Revenue |
HyperMed Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 11,801,666 | $0.001000 | 8% | $1 | $1 | 1x | $1 | 31.45% |
HyperMed Patents
HyperMed Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3176544-A1 | Portable hyperspectral imaging device | Pending | 23-Apr-2020 | ||
| US-20230157549-A1 | Portable hyperspectral imaging device | Inactive | 23-Apr-2020 | ||
| WO-2021216922-A1 | Portable hyperspectral imaging device | Inactive | 23-Apr-2020 | ||
| CA-3112470-A1 | Hyperspectral imaging method and device | Pending | 13-Sep-2018 | ||
| EP-3849659-A1 | Hyperspectral imaging method and device | Inactive | 13-Sep-2018 | G01J3/2823 |
HyperMed Signals
HyperMed Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Biomark Capital | PE/Buyout | Minority | ||
| Burrill & Co | Merchant Banking Firm | Minority | ||
| Dws Investment | Asset Manager | Minority | ||
| Kluz Ventures | Venture Capital | Minority |
HyperMed FAQs
-
When was HyperMed founded?
HyperMed was founded in 1997.
-
Where is HyperMed headquartered?
HyperMed is headquartered in Memphis, TN.
-
What is the size of HyperMed?
HyperMed has 7 total employees.
-
What industry is HyperMed in?
HyperMed’s primary industry is Diagnostic Equipment.
-
Is HyperMed a private or public company?
HyperMed is a Private company.
-
What is HyperMed’s current revenue?
The current revenue for HyperMed is .
-
How much funding has HyperMed raised over time?
HyperMed has raised $18.6M.
-
Who are HyperMed’s investors?
Biomark Capital, Burrill & Co, Dws Investment, and Kluz Ventures have invested in HyperMed.
-
When was HyperMed acquired?
HyperMed was acquired on 11-May-2025.
-
Who acquired HyperMed?
HyperMed was acquired by SafetySpect.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process